True Wealth Design »

Zentalis Pharmaceuticals shares owned by True Wealth Design

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by True Wealth Design from 13F filings

Historical chart of True Wealth Design investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by True Wealth Design consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by True Wealth Design

Quarter filed Position value Share count Share price at filing
2024-09-30 $777 211 3.68

More positions owned by True Wealth Design

Ea Series Trust Alpha Arch 1-3 (BOXX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Val (DFSV)
T Rowe Price Etf Floating Rate (TFLR)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)

View all positions for True Wealth Design

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
Vanguard Group
BlackRock
BlackRock
Decheng Capital
State Street Corporation
Citadel Advisors
Morgan Stanley
PRIMECAP Management Company
MPM Oncology Impact Management
Geode Capital Management
D. E. Shaw & Co
Woodline Partners
Two Sigma Investments

View all funds holding Zentalis Pharmaceuticals